Meta-analysis of Efficacy of Topotecan and Other Treatments for Recurrent Carcinoma of the Cervix
N/A
21 Years
N/A
21 Years
N/A
Not Enrolling
Female
Cervical Intraepithelial Neoplasia
Female
Cervical Intraepithelial Neoplasia
Trial Information
Meta-analysis of Efficacy of Topotecan and Other Treatments for Recurrent Carcinoma of the Cervix
Studies included in the meta-analysis were: GOG-0179, GOG-0204 & GOG-0169
Inclusion Criteria:
- Randomised Clinical Trials or systematic reviews or meta-analyses
- Treatment with topotecan or platinum-based single and combination regimens in female
patients of any race with cancer of the cervix recurrent after radiotherapy or stage
IVB disease
Exclusion Criteria:
- None
Type of Study:
Observational
Study Design:
Time Perspective: Retrospective
Outcome Measure:
Survival
Outcome Time Frame:
12 months
Principal Investigator
GSK Clinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
GlaxoSmithKline
Authority:
United Kingdom: Medicines and Healthcare Products Regulatory Agency
Study ID:
114015
NCT ID:
NCT01160185
Start Date:
June 2009
Completion Date:
July 2009
Related Keywords:
- Cervical Intraepithelial Neoplasia
- Neoplasms
- Cervical Intraepithelial Neoplasia
- Carcinoma in Situ
Name | Location |
|---|
